The world's most expensive drugs

Genzyme drugs take four spots among the most expensive in a Forbes survey (chart). The developer's rare disease treatments Myozyme, Fabrazyme, Cerezyme and Aldurazyme all cost over $200,000 per year. But the Cerezyme price is likely to head south following last week's FDA approval of Shire's Gaucher treatment, velaglucerase alfa for injection. Alexion Pharmaceuticals takes the top spot for the world's most expensive drug, Soliris. The therapy costs $409,500 per year. Chart | Article | Genzyme release

Suggested Articles

Lonza CEO Marc Funk is leaving for "personal reasons" after less than a year in the top job. 

Drugmakers have voluntarily recalled their generic Zantac from the U.S. market after the FDA raised concerns, but it has not been without a cost.

Just weeks after selling the sterile manufacturing assets of its Kyowa operation in Japan, it has unloaded the rest of its Kyowa drugmaking operation.